Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry.
Rungroj KrittayaphongThoranis ChantraratRoj RojjarekampaiPongpun JitthamPoom SairatGregory Yoke Hong LipPublished in: Journal of clinical medicine (2020)
Poor TTR control is associated with adverse clinical outcomes in patients with NVAF who were on warfarin. Efforts to ensure good TTR (≥65%) after initiation of warfarin are mandatory to minimize the risk of adverse clinical outcomes.